Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR for ES‐NSCLC in a hospital setting. METHODS: A single‐in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Zheng, Xiaoli, Sun, Yanan, Ye, Ke, Fan, Chengcheng, Wang, Xiaohui, Yang, Yang, Jiao, Ruidi, Ge, Hong
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952798/
https://ncbi.nlm.nih.gov/pubmed/33529496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13768
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars